Omega-3 (EPA/DHA)

fish oil · EPA · DHA · omega-3 fatty acids

Marine omega-3 fatty acids promoted for heart, brain and 'anti-inflammatory' aging.

TypeSupplement / dietary

The grade answers: What does the human evidence support for: Cardiometabolic & inflammatory support?

Grade

Limited

The grade rates evidence quality — it is not advice to take or buy.

Class: Essential fatty acids
Primary use: Cardiometabolic & inflammatory support
Evidence strength: medium
Last reviewed: 2026-07-01

Bottom line

Clearly useful for lowering triglycerides and in specific high-risk cardiac settings — but as a broad longevity or heart-protection pill for healthy people, the large trials are underwhelming.

What the evidence says

Omega-3s (EPA/DHA) have one of the largest randomized-trial programs of any supplement, which is exactly why the honest read is measured. High-dose prescription EPA cut cardiovascular events in people with high triglycerides already on statins (the REDUCE-IT setting), but a large general-population prevention trial (VITAL) found no significant reduction in major cardiovascular events or cancer. Triglyceride-lowering is robust; effects on cognition and 'inflammaging' are mixed. Hence grade C: real, targeted benefits — not the universal longevity insurance it is often sold as.

Key studies

[1]
VITAL — marine omega-3 for cardiovascular disease and cancer prevention · RCT
No significant reduction in major events in a general population.
Open on PubMed ↗
[2]
High-dose EPA in high-triglyceride patients on statins · RCT
Event reduction — but in a specific high-risk, high-dose setting.
Open on PubMed ↗
[3]
Omega-3 and cognitive aging · review
Mixed; no reliable benefit for preventing cognitive decline broadly.
Open on PubMed ↗

See all studies on PubMed ↗

Scoped PubMed search, not a curated bibliography: the individual PMIDs for this entry have not yet been verified one by one. For that reason it is not used to support a high grade and is awaiting review.

Mechanism

EPA/DHA incorporate into cell membranes and feed eicosanoid and specialised pro-resolving mediator pathways, lowering triglycerides and modulating inflammation; they also change membrane fluidity and signalling.

Safety

Generally safe. High doses can cause a fishy aftertaste and GI upset, mildly prolong bleeding time, and were linked to a small increase in atrial fibrillation in some high-dose trials. Product quality and oxidation vary between brands.

Dosage context

Dietary guidance favours two oily-fish meals per week. Supplement trials span roughly 1–4 g/day of EPA+DHA; importantly, the cardiovascular-event evidence is specific to high-dose prescription EPA in high-triglyceride patients, not low-dose over-the-counter fish oil taken by everyone.

Examples of application

Covered first by eating oily fish a couple of times a week.
As a supplement, taken with a meal to aid absorption.
High-dose prescription EPA is a specific medical case, not general use.

From the field

A molecule where the big population trials matter more than the mechanism. We keep it at C because 'good for triglycerides and specific patients' is true, while 'everyone should take it for longevity' isn't what the large RCTs show.

Follow this entry

We'll tell you if the grade for Omega-3 (EPA/DHA) changes.

One review a week: new evidence, grade changes and what was updated. No hype, no promotions disguised as news.

How we assign grades → Method